The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (1 analysts) rates it none, with a mean price target of $12.
Icahn Enterprises L.P.
IEP · Nasdaq · USD · Market cap $5.0B · 13,562 employees
Icahn Enterprises L.P., through its subsidiaries engages in the investment, energy, automotive, food packaging, real estate, home fashion and pharma in the United States and internationally.
FAIL · Does not pass the screenAt the last full screen
2026-09-11
Screened 2026-09-11 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Icahn Enterprises L.P. holds its Accumulation at $7.00. Consolidating, no directional conviction, held for 265 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 265 days |
| Price at the screen | $7.00 |
| Valuation | N/A trailing · 8.64 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.72 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 46.54% | Below 33% | Interest-bearing debt is 46.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 15.84% | Below 33% | Cash held in interest-bearing accounts and securities is 15.8% of assets, under the one-third limit. | Pass |
| Receivables | 12.97% | Below 49% | Money owed to the company is 13.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 3.10% | Below 5% | Only 3.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. The price runs 19.8% above the base estimate.
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsOil cycles turn cheap multiples into traps
Refining is a business where a sudden drop in crack spreads can wipe out years of supposed value. Icahn Enterprises shows 20% revenue growth yet posts a negative 3% profit margin and minus 10% return on equity. The forward multiple of 9.2 times looks attractive until you remember that peak-cycle earnings always compress the next time oil prices turn.
We pass because the low multiple signals a classic cyclical value trap rather than an opportunity. The company operates across energy, autos and investments, but none of those segments escape the same boom-and-bust pattern. One analyst target sits at 12 dollars, yet the opportunity rating remains none once the cycle lens is applied.
Currency moves, refinery outages and demand shocks sit on top of already negative returns on capital. Ethical screens clear, but the numbers still point to earnings that are likely inflated by the current part of the cycle. Analysis, not advice.
| Forward P/E | 8.6xcheap for a company growing this fast |
| EPS, trailing | -0.66 |
| EPS, forward | 0.81 |
| Revenue growth | +25.7%strong top-line growth |
| Profit margin | -5.0%currently unprofitable |
| Return on equity | -17.8%not currently earning a positive return on equity |
| FCF yield | 2.77% |
| Dividend yield | 2,706.00% |
| Debt to equity | 3.19heavy leverage: higher risk if revenue softens |
| Current ratio | 1.65healthy short-term liquidity |
| Beta | 0.72steadier than the market |
| Short interest, float | 0.11% |
| 52-week range | 6.51 - 9.32 |
| Market cap | $5.0B |
| Employees | 13,562 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeIEP trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (1 analysts) rates it none, with a mean price target of $12.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (1 analysts) rates it none, with a mean price target of $12.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $7.61 | -4.6% | $0.50 | $1,020 | +2.0% |
| 2 months | $7.16 | +1.3% | $0.50 | $1,082 | +8.2% |
| 3 months | $7.13 | +1.8% | $0.50 | $1,088 | +8.8% |
| 6 months | $6.85 | +6.0% | $1.00 | $1,206 | +20.6% |
| 1 year | $6.58 | +10.3% | $2.00 | $1,408 | +40.8% |
| 2 years | $10.51 | -31.0% | $4.50 | $1,119 | +11.9% |
| 3 years | $14.61 | -50.3% | $8.50 | $1,079 | +7.9% |
| 5 years | $21.25 | -65.9% | $24.50 | $1,495 | +49.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever IEP does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.